This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2000 May;31(5):1037-44.

doi: 10.1053/he.2000.6709.

Clinical relevance of hepatitis B viral mutations

C M Hunt¹, J M McGill, M I Allen, L D Condreay

Affiliations

PMID: 10796877
DOI: 10.1053/he.2000.6709

Review

Clinical relevance of hepatitis B viral mutations

C M Hunt et al. Hepatology. 2000 May.

. 2000 May;31(5):1037-44.

doi: 10.1053/he.2000.6709.

Authors

C M Hunt¹, J M McGill, M I Allen, L D Condreay

Affiliation

¹ Departments of Clinical Research, Glaxo Wellcome Inc., Research Triangle Park, NC, USA.

PMID: 10796877
DOI: 10.1053/he.2000.6709

No abstract available

PubMed Disclaimer

Similar articles

Genetic variants of hepatitis B virus and their clinical relevance.
Baumert TF, Barth H, Blum HE. Baumert TF, et al. Minerva Gastroenterol Dietol. 2005 Mar;51(1):95-108. Minerva Gastroenterol Dietol. 2005. PMID: 15756149 Review.
Hepatitis B virus genetic diversity.
Echevarría JM, Avellón A. Echevarría JM, et al. J Med Virol. 2006;78 Suppl 1:S36-42. doi: 10.1002/jmv.20605. J Med Virol. 2006. PMID: 16622876
[Analysis of the relevance of the mutations of the precore and basic core promoter in HBV genome with the DNA amount of HBV viremia].
Kaijima H, Yukimasa N, Sugano E, Yasuhara T, Fukuchi K, Gomi K. Kaijima H, et al. Rinsho Byori. 2009 Apr;57(4):332-7. Rinsho Byori. 2009. PMID: 19489434 Japanese.
Low-abundance drug resistance mutations: extending the HIV paradigm to hepatitis B virus.
Menzo S, Vincenti D, Solmone M, Prosperi M, Bruselles A, Abbate I, Rozera G, Capobianchi MR. Menzo S, et al. J Infect Dis. 2009 Dec 1;200(11):1798-9; author reply 1799-1800. doi: 10.1086/647991. J Infect Dis. 2009. PMID: 19905934 No abstract available.
[Risks and precautions for the use of lamivudine in patients with chronic hepatitis B virus infection].
Andreani T, Chazouillères O, Calmus Y, Poupon R. Andreani T, et al. Gastroenterol Clin Biol. 2002 Jan;26(1):51-6. Gastroenterol Clin Biol. 2002. PMID: 11938040 Review. French. No abstract available.

See all similar articles

Cited by

Sensitive detection of HBsAg mutants by a gap ligase chain reaction assay.
Osiowy C. Osiowy C. J Clin Microbiol. 2002 Jul;40(7):2566-71. doi: 10.1128/JCM.40.7.2566-2571.2002. J Clin Microbiol. 2002. PMID: 12089278 Free PMC article.
How will we use the new antiviral agents for hepatitis B?
Perrillo RP. Perrillo RP. Curr Gastroenterol Rep. 2002 Feb;4(1):63-71. doi: 10.1007/s11894-002-0039-6. Curr Gastroenterol Rep. 2002. PMID: 11825543 Review.
Current status of antiviral therapy for hepatitis B.
Lau DT, Bleibel W. Lau DT, et al. Therap Adv Gastroenterol. 2008 Jul;1(1):61-75. doi: 10.1177/1756283X08093944. Therap Adv Gastroenterol. 2008. PMID: 21180515 Free PMC article.
The importance of hepatitis B virus genome diversity in Basal core promoter region.
Mohamadkhani A, Montazeri G, Poustchi H. Mohamadkhani A, et al. Middle East J Dig Dis. 2011 Mar;3(1):13-9. Middle East J Dig Dis. 2011. PMID: 25197527 Free PMC article. Review.
Treatment of hepatitis B virus: an update.
Ward H, Tang L, Poonia B, Kottilil S. Ward H, et al. Future Microbiol. 2016 Dec;11(12):1581-1597. doi: 10.2217/fmb-2016-0128. Epub 2016 Nov 18. Future Microbiol. 2016. PMID: 27855500 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database